The binding of cyclosporin a to human plasma: An in vitro microdialysis study

Pharmaceutical Research

Volumn 13, Issue 4, 1996, Pages 622-627

  Yang, Hua ^a,b   Elmquist, William F ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cyclosporin A; Microdialysis; Plasma free fraction; Thermodynamics of binding

Indexed keywords

CYCLOSPORIN A;

ARTICLE; DRUG PROTEIN BINDING; HUMAN; IN VITRO STUDY; MICRODIALYSIS; PRIORITY JOURNAL; TEMPERATURE; THERMODYNAMICS;

BLOOD PROTEINS; CHEMICAL FRACTIONATION; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOTOPE LABELING; MICRODIALYSIS; PROTEIN BINDING; TEMPERATURE; THERMODYNAMICS; TRITIUM;

EID: 0029996133     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016066609489     Document Type: Article

References (29)

1. J. F. Borel. In D. J. G. White (ed.), Cyclopsorin A-Proceedings of an International Conference on Cyclosporin A, Cambridge, Sept. 1981, Elsevier, Amsterdam, 1982, pp. 5-17.
2. H. Shulman, G. Striker, H. J. Deeg, M. Kennedy, R. Strob, and E. D. Thomas. Nephrotoxicity of cyclopsorin A after allogenic bone marrow transplantation: Glomerular thromboses and tubular injury. New England J. Med. 305(23):1392-1395 (1981).
3. E. Gluckman, A. Devergie, F. Lokiec, O. Poirier, and A. Baumelou. Nephrotoxicity of cyclosporin A in bone marrow transplantation. Lancet July 18:144-145 (1981).
4. K. Atkinson, J. Biggs, P. Darveniza, J. Boland, A. Cocannon, and A. Dodds. Cyclosporine-associated central nervous system toxicity after allogenic bone marrow transplantation. Transplantation 38:34-37 (1984).
5. K. Atkinson, Biggs, A. Dodds, and A. Cocannon. Cyclosporine-associated hepatotoxicity after allogenic marrow transplantation in man: Differentiation from other causes of posttransplant liver disease. Trans. Proceedings 15:2761-2767 (1983).
6. A. Lindholm. Factors influencing the pharmacokinetics of cyclopsorine in man. Ther. Drug Monit. 13:465-477 (1991).
7. G. C. Yee, T. R. McGuire, D. L. Gmur, T. P. Lennon, and H. J. Deeg. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation: Influence of age, obesity, and hematocrit. Transplantation 46:399-402 (1988).
8. A. Lindholm, O. Ringden, and B. Lonnqvist. The role of cyclosporine dosage and plasma levels in the efficiacy and toxicity in bone marrow transplant recipients. Transplantation 43:680-684 (1984).
9. G. C. Yee. Pharmacokinetic and pharmacodynamic studies of cyclopsorine in bone marrow transplantation. Trans. Proceedings 22:1327-1330 (1990).
10. J. C. Biggs, K. Atkinson, K. Britton, and K. Downs. The use of cyclosporine in human marrow transplantation: Absence of a therapeutic window. Trans. Proceedings 17:1239-1241 (1985).
11. B. Legg and M. Rowland. Cyclosporin: measurement of fraction unbound in plasma. J. Pharm. Pharmacol. 39:599-603 (1987).
12. A. Lindholm and S. Henricsson. Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants. Ther. Drug Monit. 11:623-630 (1989).
13. I. Zaghloul, R. J. Ptachcinski, G. J. Burckart, D. Van Thiel, E. Starzel, and R. Venkataramanan. Blood protein binding of cyclosporine in transplant patients. J. Clin. Pharmacol. 27:240-242 (1987).
14. W. Awni, K. Heim-Duthoy, and K. V. Rao. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: Effects of binding and metabolism. Clin. Pharmacol. Ther. 45:41-48 (1989).
15. W. Awni, K. Heim-Duthoy, and B. L. Kasiske. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activities in transplant patients. Trans. Proceedings 22:1193-1196 (1990).
16. W. Awni and R. J. Sawchuk. The pharmacokinetics of cyclosporine: II. Blood plasma distribution and binding studies. Drug Meta. Dispo. 13:133-138 (1985).
17. M. Lemaire and J. P. Tillement. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporine A in the blood. J. Pharm. Pharmacol. 34:715-718 (1982).
18. S. Henricsson. A new method for measuring the free fraction of cyclosporin in plasma by equilibrium dialysis. J. Pharm. Pharmacol. 39:384-385 (1986).
19. U. Ungerstedt. Microdialysis-principles and applications for studies in animals and man. J. Int. Med. 230:365-373 (1991).
20. A. M. Herrera, D. O. Scott, and C. E. Lunte. Microdialysis sampling for the determination of plasma protein binding of drugs. Pharm. Res. 7:1077-1081 (1990).
21. M. Ekblom, M. Hammarlund-Undenaes, T. Lundqvist, and P. Sjoberg. Potential use of microdialysis in pharmacokinetics: A protein binding study. Pharm. Res. 9:155-158 (1992).
22. B. Legg and M. Rowland. Cyclosporin: Erythrocyte binding and an examination of its use to estimate unbound concentration. Them. Drug Monit. 10:16-19 (1988).
23. B. Legg and M. Rowland. Saturable binding of cyclosporin A to erythrocytes: Estimation of binding parameters in renal transplant patients and implications for bioavailability assessment. Pharm. Res. 5:80-85 (1988).
24. B. Legg, S. K. Gupta, and M. Rowland. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients. Thera. Drug Monit. 10:20-27 (1988).
25. A. K. Shah, R. C. Brundage, K. D. Lake, and R. J. Sawchuk. The estimation of the plasma free fraction of cyclosporine in rabbits and heart transplant patients: the application of a physiological model of renal clearance. Biopharm. Drug Dispo. 16:59-70 (1995).
26. W. Niederberger, M. Lemaire, G. Maurer, K. Nussbaumer, and O. Wagner. Distribution and binding of cyclosporine in blood and tissues. Trans Proceedings 15:2419-2421 (1983).
27. N. Lindefors, G. Amberg, and U. Ungerstedt. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 22:141-156 (1989).
28. G. Amberg and N. Lindefors. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J. Pharmacol. Methods 22:157-183 (1989).
29. Y. Wang, S. L. Wong, and R. J. Sawchuk. Microdialysis calibration using retrodialysis and zero-net flux: Application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm. Res. 10:1411-1419 (1993).